Similar articles for PMID: 10471491

Year	Number of Results
1951	1
1953	1
1954	2
1955	3
1981	1
1994	2
1995	5
1996	5
1997	1
1998	4
1999	6
2000	6
2001	11
2002	6
2003	6
2004	3
2005	12
2006	1
2007	1
2009	1
2010	2
2011	1
2012	1
2015	1
2016	1
2017	3
2018	1
2019	1
2021	1
2024	0

1

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP, Radvanyi F. Cappellen D, et al. Nat Genet. 1999 Sep;23(1):18-20. doi: 10.1038/12615. Nat Genet. 1999. PMID: 10471491 No abstract available.

2

Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.

Wu R, Connolly D, Ngelangel C, Bosch FX, Muñoz N, Cho KR. Wu R, et al. Oncogene. 2000 Nov 16;19(48):5543-6. doi: 10.1038/sj.onc.1203934. Oncogene. 2000. PMID: 11114733

3

Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.

Dunois-Lardé C, Levrel O, Brams A, Thiery JP, Radvanyi F. Dunois-Lardé C, et al. Mol Carcinog. 2005 Mar;42(3):142-9. doi: 10.1002/mc.20075. Mol Carcinog. 2005. PMID: 15690367

4

Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.

Gómez-Román JJ, Saenz P, Molina M, Cuevas González J, Escuredo K, Santa Cruz S, Junquera C, Simón L, Martínez A, Gutiérrez Baños JL, López-Brea M, Esparza C, Val-Bernal JF. Gómez-Román JJ, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):459-65. Clin Cancer Res. 2005. PMID: 15701828

5

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.

van Rhijn BW, van Tilborg AA, Lurkin I, Bonaventure J, de Vries A, Thiery JP, van der Kwast TH, Zwarthoff EC, Radvanyi F. van Rhijn BW, et al. Eur J Hum Genet. 2002 Dec;10(12):819-24. doi: 10.1038/sj.ejhg.5200883. Eur J Hum Genet. 2002. PMID: 12461689

6

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.

Billerey C, Chopin D, Aubriot-Lorton MH, Ricol D, Gil Diez de Medina S, Van Rhijn B, Bralet MP, Lefrere-Belda MA, Lahaye JB, Abbou CC, Bonaventure J, Zafrani ES, van der Kwast T, Thiery JP, Radvanyi F. Billerey C, et al. Am J Pathol. 2001 Jun;158(6):1955-9. doi: 10.1016/S0002-9440(10)64665-2. Am J Pathol. 2001. PMID: 11395371 Free PMC article.

7

Frequent FGFR3 mutations in urothelial papilloma.

van Rhijn BW, Montironi R, Zwarthoff EC, Jöbsis AC, van der Kwast TH. van Rhijn BW, et al. J Pathol. 2002 Oct;198(2):245-51. doi: 10.1002/path.1202. J Pathol. 2002. PMID: 12237885

8

No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer.

Naimi B, Latil A, Berthon P, Cussenot O. Naimi B, et al. Int J Cancer. 2000 Aug 1;87(3):455-6. Int J Cancer. 2000. PMID: 10897055 Free article. No abstract available.

9

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.

van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC. van Rhijn BW, et al. Cancer Res. 2001 Feb 15;61(4):1265-8. Cancer Res. 2001. PMID: 11245416

10

Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection.

Rieger-Christ KM, Mourtzinos A, Lee PJ, Zagha RM, Cain J, Silverman M, Libertino JA, Summerhayes IC. Rieger-Christ KM, et al. Cancer. 2003 Aug 15;98(4):737-44. doi: 10.1002/cncr.11536. Cancer. 2003. PMID: 12910517 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year